Stock report · Delisted · Nasdaq
Accolade, Inc. (ACCD)
7.02USD Delisted Final close · Apr 7, 2025
ACCD no longer trades. Accolade was delisted from the Nasdaq in April 2025.
All prices on this page are historical. The last trade was on April 7, 2025, at $7.02.
ACCD stock price history
Final trading statistics
- Final close
- $7.02
- Final trading day
- Apr 7, 2025
- Market cap at delisting
- $575.59M
- Shares outstanding
- 81.99M
- Final 52-week range
- $3.08 – $9.67
- Avg. volume (final 3 mo.)
- 2,113,600
- All-time high
- $59.72 · Dec 2020
- All-time low
- $3.15 · Nov 2024
- Return since IPO
- -76.6%
- Beta
- 2.10
- Book value / share
- $3.85
- Price / book
- 1.82
About Accolade, Inc.
Accolade, with its subsidiaries, offered personalized, technology-based services that helped people in the U.S. understand and use the healthcare system and their workplace benefits. Its cloud platform was backed by advocates and clinicians, including nurses, physician medical directors, pharmacists, behavioral and women's health specialists, case managers and primary care doctors.
Services included expert medical opinions, navigation and advocacy, specialist consultations for adults and children, and primary care and mental health support. Employers used it to give workers and their families one place to go for health and benefits needs.
The company was incorporated in 2007 and based in Seattle, Washington. Its shares were delisted from the Nasdaq in April 2025, with the final trade on April 7, 2025 at $7.02.
- Exchange (former)
- Nasdaq
- Sector
- Healthcare
- Industry
- Health Information Services
- Headquarters
- Seattle, WA
- Employees
- 2,400
- IPO date
- July 2, 2020
- Delisted
- April 7, 2025
- SEC CIK
- 1481646
Accolade financials before the delisting
The last 5 fiscal years Accolade reported as a public company, fiscal year ending February.
ACCD revenue and net income
ACCD earnings per share
ACCD annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $414.29M | −$99.8M | −$1.33 |
| FY2023 | $363.14M | −$459.6M | −$2.26 |
| FY2022 | $310.02M | −$123.1M | −$1.83 |
| FY2021 | $170.36M | −$50.7M | −$2.87 |
| FY2020 | $132.51M | −$51.4M | −$0.88 |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
Accolade stock FAQ
What happened to Accolade stock?
Accolade was delisted from the Nasdaq in April 2025. The final close was $7.02 on April 7, 2025.
Can I still buy ACCD stock?
No. ACCD is no longer listed on the Nasdaq or any other U.S. exchange; it was removed on April 7, 2025.
What was the last price of ACCD?
ACCD last closed at $7.02 on April 7, 2025, which valued the company at about $575.59M.
How did Accolade do in its last full fiscal year?
In fiscal 2024, its last full year as a public company, Accolade reported revenue of $414.29M and net income of −$99.8M.
When did Accolade go public?
Accolade shares started trading on July 2, 2020.
ACCD no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.